Skip to content

LIght Sedation Pressure Support

Early LIght Sedation Pressure Support in ARDS Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03783468
Acronym
LIPS
Enrollment
0
Registered
2018-12-21
Start date
2021-12-31
Completion date
2023-12-31
Last updated
2022-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Human

Brief summary

Sedation may have many drawbacks in ICU patients: cardiovascular, neurologic, muscular. Light sedation and Pressure Support ventilation is feasible in ARDS patients. However spontaneous breathing can lead to high transpulmonary pressure. The goal of the study is to measure transpulmonary pressure before sedation decrease and after stabilization. The main endpoint is transpulmonary pressure less than 24 cmH2O.

Interventions

OTHERdecrease of sedation doses and switch of ventilator settings

tapering sedation doses (propofol) switch from assisted ventilation to pressure support ventilation

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ARDS (Berlin definition) * social insurance

Exclusion criteria

* neuromuscular disorders * pregnancy * need for muscular paralysis * need for deep neurosedation * more than 24hrs of artificial ventilation * cystic fibrosis

Design outcomes

Primary

MeasureTime frameDescription
transpulmonary pressure at early stabilization of patientwhen patient is conscious and stable (no modification of ventilator settings) generally within 2 hourstranspulmonary pressure (Paw - Peso \< 24 cmH2O)

Secondary

MeasureTime frameDescription
arterial pressure modificationstabilization of ventilator settings; 1hour after stabilization of ventilator settingsMean arterial pressure
Heart rate modificationstabilization of ventilator settings;1hour after stabilization of ventilator settingsheart rate
vasopressor dose modificationstabilization of ventilator settings ; 1hour after stabilization of ventilator settingsvasopressor dose in norepinephrine equivalent
acquired neuromyopathyICU discharge, an average 16 daysMRC \<48/60
muscular volume decreaseat 24 hours; at day of extubation; ICU discharge, an average 16 daysquadriceps volume assessed by echography
oxygenation modificationstabilization of ventilator settings; 1hour after stabilization of ventilator settingsPaO2/FiO2
delirium in ICUICU discharge, an average 16 daysCAM-ICU is a valid and reliable delirium assessment tool recommended by the Society of Critical Care Medicine (SCCM) in its 2013 Pain, Agitation and Delirium (PAD) guidelines. the presence of delirium is confirmed in the presence of criteria 1, 2 and 3 or 4.
change of the functional respiratory parameters from baseline at 6 monthsat 6 monthsvital capacity, total pulmonary capacity,
PTSDat 6 monthspost traumatic stress disorder impact of event scale \> 33 tems are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely) and the total score (ranging from 0 to 88)
number of auto extubationwhatever until ICU discharge, an average 16 days
ventilator free daysduring the first 28 daysventilator free days until day 28

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026